Advertisement

Topics

Latest "The American Society for Cell Biology" News Stories

20:24 EST 17th November 2018 | BioPortfolio

Here are the most relevant search results for "The American Society for Cell Biology" found in our extensive news archives from over 250 global news sources.

More Information about The American Society for Cell Biology on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about The American Society for Cell Biology for you to read. Along with our medical data and news we also list The American Society for Cell Biology Clinical Trials, which are updated daily. BioPortfolio also has a large database of The American Society for Cell Biology Companies for you to search.

Showing "American Society Cell Biology" News Articles 1–25 of 17,000+

Saturday 17th November 2018

Week in Review: CStone Pharma, a Suzhou Oncology Company, Files for Hong Kong IPO

Deals and Financings  Suzhou's CStone Pharma filed for a Hong Kong IPO to develop its portfolio of 14 oncology candidates including PD-1, PD-L1 and CTLA-4 antibodies; LG Chem Life Sciences of South Korea formed a nearly $1 billion three-candidate IO collaboration with Cue Biopharma, a Boston area IO company; Agilent Technologies closed its $250 million acquisition of ACEA Biosciences, a San ...


Single Cell RNA-Seq Scrutinized by Neural Nets: http://ow.ly/xgoH30mBnMe pic.twitter.com/sVvEP5748u

Single Cell RNA-Seq Scrutinized by Neural Nets: http://ow.ly/xgoH30mBnMe  pic.twitter.com/sVvEP5748u

ReproCELL Inc 4978 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryReproCELL Inc ReproCELL is a biotechnology company that develops and commercializes stem cell technologies. The company offers products in divisions such as research reagents, cultivation materials, and cell and biorepository. Its research reagent products include hES iPSC culture reagents, human HSC culture reagent, reprogramming regent for iPSC, small molecule, pluripotency marker, and cu...


Centre for Commercialization of Regenerative Medicine Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryCentre for Commercialization of Regenerative Medicine CCRM is a healthcare service provider that offers cell reprogramming and engineering, cell manufacturing, biomaterials and devices manufacturing, and protocol development services. The center harnesses the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs. It provides busi...

The Premiere of Your Life by Design Podcast with Dr. Sundardas D. Annamalay - Win a Private Consultation with Dr. Sundardas

Multiple award-winning entrepreneur, best-selling author, professor of natural medicine, and naturopathic physician, Dr. Sundardas D. Annamalay (Dr. Sun) premieres his brand new podcast, Your Life by Design. Plus one lucky listener each week, who posts a review on iTunes, will win a private transformational consultation with Dr. Sundardas to discover his/her unique soul purpose. SINGAPORE (PRWEB) ...

With New HQ, Ipsen to Rapidly Expand North American Presence http://dlvr.it/QrTLjH pic.twitter.com/xrKKMchkMK

With New HQ, Ipsen to Rapidly Expand North American Presence http://dlvr.it/QrTLjH  pic.twitter.com/xrKKMchkMK

Biomnis SELAS Medical Equipment Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryBiomnis SELAS Biomnis, a subsidiary of Eurofins Scientific SE is a provider of medical laboratory testing services. The company offers laboratory tests in the areas of generics, biochemistry, immunology, cytogenics, oncohaemotology, analytical chemistry, assisted reproductive technologyembrologysperm science, genetic fingerprinting, molecular biology, infectiology, and others. It also provi...

Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10 Pipeline Review, H2 2018 [Report Updated: 14082018] Prices from USD $3500

Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10 Pipeline Review, H2 2018SummaryInhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10 pipeline Target constitutes close to 8 molecules. Out of which app...

hVIVO Plc HVO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryhVIVO Plc hVIVO, formerly Retroscreen Virology Ltd is a biopharma company that develops humanbased analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human disease model platform to study new drugs and investigate diseases. hVIVO offers services such as viral ch...

Obesity significantly increases risk of Type 2 diabetes and coronary artery disease

A Cleveland Clinic genetic analysis has found that obesity itself, not just the adverse health effects associated with it, significantly increases the risk of Type 2 diabetes and coronary artery disease. The paper was published today in the Journal of the American Medical Association Network Open.

SomaLogic Inc Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummarySomaLogic Inc SomaLogic is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company's products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies and aptamers, which is used in clinical diagnosis of EDTA plasma, citrate plasma...

New method to analyze cell membrane complexes could revolutionize the way we study diseases

Researchers have developed a new technique to analyze cell membrane proteins in situ which could revolutionize the way in which we study diseases, such as cancer, metabolic and heart diseases.

Researchers show how proteins interact in hypoxic conditions to facilitate mitochondrial fission

During a heart attack the supply of oxygen to heart cells is decreased. This reduced oxygen level, called hypoxia, causes the cell's powerhouses, the mitochondria, to fragment, impairing cell function and leading to heart failure. Until now, few details were known on how this important process occurs.

Global and Asia Lithium Aluminium Hydride LAH Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

University of Rochester Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryUniversity of Rochester UOR is an educational university that offers research and development services. The university performs research in the areas of humanities, engineering medical education, medicine, geology, optics, economics, political theory, human behavior, and social and natural sciences. It offers various programs such as actuarial studies, American Sign Language, American studi...

BioStem Technologies Inc BSEM Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryBioStem Technologies Inc. BioStem Technologies, formerly Caribbean International Holdings Inc., is a life sciences company that discovers, develops and manufactures pharmaceuticals and regenerative medicines. Through its subsidiaries, the company discovers, develops, produces and commercializes stem cell and wellness products. It provides regenerative biologics for the treatment of muscular...

Friday 16th November 2018

MKSAP: 42-year-old man with thrombophilia

Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. A 42-year-old man arrives for follow-up consultation. Three months ago he developed a proximal right leg deep venous thrombosis following a skiing-related fracture of the right tibia. Although not recommended by guidelines, a thrombophilia evaluation was performed, which revealed an ele...

Horizon Discovery Group Plc HZD Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryHorizon Discovery Group Plc Horizon Discovery is a life science company that discovers and develops geneticallymodified cell lines using a proprietary translational genomics platform. The company offers products such as cell lines, reference standards and in vivo models. It also offers services such as CRISPR screening, combination screening, in vivo assay services and cellbased assays, amo...

Consejo Superior de Investigaciones Cientificas Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryConsejo Superior de Investigaciones Cientificas CSIC is a research institute that offers research capacity, and human and material resources to conduct research projects. The institute offers multidisciplinary scientific and technical research, scientific and technical advice, management of infrastructures and large facilities, and others. Its scientific areas include humanities and social ...

MobileHelp® Healthcare Expands Diabetes Management Platform with Polymap Wireless

BOCA RATON, Fla., Nov. 16, 2018 /PRNewswire/ -- As American Diabetes Month kicks off this November to raise awareness for the disease that impacts more Read more...

Sensors: Technologies and Markets in North America (2018-2023) by Type, End-Use Industry, ...

DUBLIN, Nov. 16, 2018 /PRNewswire/ -- The "Sensors: Technologies and North American Markets" report has been added to ResearchAndMarkets.com's offering. The North American region has Read more...

Global Primary Cell Culture Market Analysis by Product, Application, Separation Culture Method, ...

DUBLIN, Nov. 16, 2018 /PRNewswire/ -- The "Primary Cell Culture Market Analysis Report By Product, By Application (Stem Cell Therapy, Vaccine Production), By Separation and Read more...

World Institute of Kimchi: Function-enhanced kimchi inhibits growth of cancer cells

Proven anticancer effects of Amtak Baechu cabbage, a crossbred of turnip and Baechu cabbage Intake of kimchi made with Amtak Baechu cabbage doubles the rate of pancreatic cancer cell inhibition compared with standard kimchi SEOUL, South Korea, Nov. 16, 2018 /PRNewswire/ -- Worl

JLK Inspection to Showcase its AI-based Medical Solutions at RSNA

Groundbreaking AI-enabled diagnosis technology is able to detect over 30 medical conditions with high-level accuracy including strokes, Alzheimer's, Thyroids cancer, Breast cancer, and Joint disease CHICAGO, Nov. 16, 2018 /PRNewswire/ -- This month JLK Inspection will participate in the Radiological Society of North America (RSNA) 2018 in Chicago, presenting ...

Nivolumab/Ipilimumab Combo Nears EU Approval for Frontline RCC

The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended approval of nivolumab combined with low-dose ipilimumab as a frontline treatment for patients with intermediate- and poor-risk advanced renal cell carcinoma.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks